Dioseve logo

Dioseve

creating human eggs from iPS cells

5 employees · est. 2021 · Japan

VS
trenzyme GmbH logo

trenzyme GmbH

As full service provider for the life science industry, we have a clear mission: Accelerating your innovation!

22 employees · est. 2000 · Konstanz, Germany

trenzyme GmbH is the older company (2021 vs 2000); trenzyme GmbH is the larger of the two.

Side-by-Side Comparison

Dioseve trenzyme GmbH
Founded
2021 2000 older
Headquarters
Japan Konstanz, Germany
Employees
5 22 larger
Industry
Biotechnology, Health Care Biotechnology, Life Sciences, Manufacturing
Funding Stage
Unknown Not tracked yet
Total Funding
$407.00M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
developing solutions for infertility using stem cell technology, inducing egg and sperm cells from iPS cells, innovative reproductive health solutions Not tracked yet
Target Customers
individuals facing infertility, couples desiring children, healthcare providers Not tracked yet
Taxonomy
IPS Cells, ES Cells, Fertility Technology, Oocyte Creation, Infertility Treatment, Reproductive Innovation, Stem Cell Research, Fertility Solutions, Reproductive Health Life Science, Contract Research Organization, Cell Line Development, Recombinant Protein Production, Cell Culture Services, Stem Cell Differentiation, GMP-Compliant, Pharmaceutical, Outsourcing Partner, Protein Expression, Toxicity Testing, Tissue Diagnostics, SARS-CoV-2 Proteins, Scientific Experts
Website
dioseve.com trenzyme.com
Dioseve logo

About Dioseve

Dioseve is a burgeoning player in the Biotechnology and Health Care industries, poised to transform infertility treatments. Founded in 2021, the company is headquartered in Japan and is devoted to the pioneering mission of "creating human eggs from iPS cells." Through its cutting-edge technology tha...

trenzyme GmbH logo

About trenzyme GmbH

trenzyme GmbH is a privately owned ISO 9001:2015 certified German Contract Research Organization (CRO) founded in 2000. As a full-service provider for the life science industry, it offers highly customized services in cell line development, iPSC differentiation, and recombinant protein production. T...

We will tell you when either one moves

BounceWatch watches Dioseve and trenzyme GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dioseve and trenzyme GmbH — by email.

Frequently Asked Questions

Dioseve — creating human eggs from iPS cells. trenzyme GmbH — As full service provider for the life science industry, we have a clear mission: Accelerating your innovation!. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dioseve has raised $407.00M while trenzyme GmbH has raised undisclosed funding.
Dioseve and trenzyme GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dioseve with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dioseve on 24 Mar 2026, and trenzyme GmbH on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy